The Use of Pentolinium Tartrate with and without Hydralazine in the Treatment of Severe Hypertension
- 22 June 1955
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 252 (25) , 1057-1066
- https://doi.org/10.1056/nejm195506232522501
Abstract
PENTOLINIUM tartrate is a pentamethonium derivative in which the two terminal quaternary nitrogen atoms are included in a pyrrolidine ring rather than each being trimethylated: This substance is an autonomiC blocking agent like its parent methonium compound. It is longer acting and has greater absolute effect on blood pressure, coupled with a relatively smaller effect on gastrointestinal motility, than the hexamethonium ion.1 2 3 Pentolinium tartrate has been used alone to lower blood pressure and thereby to permit regression of the signs and symptoms associated with severe hypertension.4 5 6 For the malignant phase of hypertension, with its poor prognosis,7 8 9 the combination of hydralazine . . .Keywords
This publication has 17 references indexed in Scilit:
- STUDIES ON THE CONTROL OF HYPERTENSION BY HYPHEX. IV. LEVELS OF THE AGENTS IN URINE AND BLOODThe Lancet Healthy Longevity, 1954
- Studies on the Control of Hypertension by HyphexCirculation, 1954
- A Clinical Appraisal of Pentapyrrolidinium (M&B 2050) in Hypertensive PatientsCirculation, 1954
- Studies on the Control of Hypertension by HyphexCirculation, 1953
- The natural history and course of hypertension with papilledema (Malignant Hypertension)American Heart Journal, 1953
- ACTION OF A NEW METHONIUM COMPOUND IN ARTERIAL HYPERTENSION PENTAMETHYLENE 1 : 5-BIS-N- (N-METHYL-PYRROLIDINIUM) BITARTRATE (M. & B. 2050A)The Lancet, 1953
- PHARMACOLOGY OF M. & B. 2050The Lancet, 1953
- NEW SYMPATHICOLYTIC AGENTSThe Lancet, 1953
- HYPERTENSIVE CARDIOVASCULAR DISEASEJAMA, 1951
- DIFFUSE ARTERIOLAR DISEASE WITH HYPERTENSION AND THE ASSOCIATED RETINAL LESIONSMedicine, 1939